Vivos Therapeutics, Inc.(VVOS)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
VVOS is scheduled to report on Nov 17, 2026, usually after the market closes. Analysts expect EPS of -$0.31.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±12.2%).
Did the stock rise after good news?
The next-day move after each of its last 5 EPS beats and 6 misses.
In plain words: it beat expectations 5 times, but the stock still fell 5 of those 5 times.
- Aug '26Beat▼ -12.2%
- May '26Missed▼ -0.8%
- Apr '26Missed▼ -25.9%
- Nov '25Beat▼ -10.2%
- Aug '25Missed▼ -3.3%
- May '25Missed▼ -17.0%
- Mar '25Beat▼ -7.7%
- Nov '24Beat▼ -9.0%
- Aug '24Beat▼ -5.1%
- May '24Missed▼ -12.4%
- Mar '24Missed▼ -30.2%
Clear beats and misses with a known reaction only. What counts as a beat
Why did VVOS fall after beating earnings?
5 of VVOS's last 11 reactions went against the EPS result. What stands out in each:
VVOS beat EPS estimates in 5 quarters, and the stock still closed lower the next day 5 times. In 3 of the 5 where we have price data, the stock had already run up before the report.
- Aug 14, 2026EPS beat +20.5%stock -12.2% next day
- It had risen 5.9% in the final week before the report, so good news may already have been priced in.
- It opened 11.1% lower as soon as trading resumed.
- Nov 19, 2025EPS beat +3.9%stock -10.2% next day
- It opened 4.2% lower as soon as trading resumed.
- Mar 31, 2025EPS beat +34.9%stock -7.7% next day
- It opened 1.1% lower as soon as trading resumed.
- Nov 14, 2024EPS beat +42.9%stock -9.0% next day
- It had risen 27.9% in the 20 trading sessions before the report, so good news may already have been priced in.
- Aug 14, 2024EPS beat +42.9%stock -5.1% next day
- It had risen 15.6% in the final week before the report, so good news may already have been priced in.
- It opened 4.2% higher, but sellers took over and it closed -5.1%.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was VVOS's earnings move already priced in?
VVOS's move in the month before each of its last 11 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 11 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does VVOS hold its opening gap after earnings?
VVOS's opening move after each report and where it closed that day.
In 10 reports VVOS opened at least 1% away from the previous close. It gave back half or more of that gap by the close 1 of 10 times (10%), and fully reversed 1 time.
- Aug 14, 2026HeldOpened -11.1%, closed -12.2%
- May 20, 2026HeldOpened -1.7%, closed -0.8%
- Apr 15, 2026HeldOpened -15.6%, closed -25.9%
- Nov 19, 2025HeldOpened -4.2%, closed -10.2%
- Aug 19, 2025HeldOpened -4.0%, closed -3.3%
- May 15, 2025HeldOpened -5.2%, closed -17.0%
- Mar 31, 2025HeldOpened -1.1%, closed -7.7%
- Aug 14, 2024ReversedOpened +4.2%, closed -5.1%
What the history says
- It fell after 5 of its 5 EPS beats (100%): beating estimates has not been enough on its own.
VVOS earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | After close | -$0.39 | -$0.31 | +20.5% | -12.24% | -19.53% |
| May 20, 2026 | After close | -$0.45 | -$0.52 | -15.6% | -0.85% | +9.66% |
| Apr 15, 2026 | After close | -$0.48 | -$0.58 | -20.8% | -25.85% | -31.29% |
| Nov 19, 2025 | After close | -$0.51 | -$0.49 | +3.9% | -10.17% | -8.90% |
| Aug 19, 2025 | After close | -$0.38 | -$0.55 | -44.7% | -3.28% | -1.64% |
| May 15, 2025 | After close | -$0.40 | -$0.45 | -12.5% | -16.99% | -29.90% |
| Mar 31, 2025 | After close | -$0.43 | -$0.28 | +34.9% | -7.72% | -9.82% |
| Nov 14, 2024 | After close | -$0.70 | -$0.40 | +42.9% | -8.97% | -9.29% |
| Aug 14, 2024 | After close | -$1.05 | -$0.60 | +42.9% | -5.11% | +9.70% |
| May 14, 2024 | After close | -$1.16 | -$1.63 | -40.5% | -12.45% | -8.03% |
| Mar 28, 2024 | After close | -$2.06 | -$2.76 | -34.0% | -30.23% | -37.68% |
| Nov 14, 2023 | After close | -$3.00 | -$3.08 | -2.7% | — | — |
Consensus for the next report: EPS -$0.31, revenue $5.98M.
VVOS Earnings FAQ
Answers computed from Vivos Therapeutics, Inc.'s reported history
VVOS is scheduled to report on Nov 17, 2026, usually after the market closes. Analysts expect EPS of -$0.31.
Over the last 12 quarters with a usable EPS surprise, VVOS beat the consensus estimate 5 times (42%), missed 7 and landed in line 0.
Across its last 11 quarters with a measured reaction, VVOS moved an average of ±12.2% in the first session after reporting. It closed higher 0% of the time; the largest gain was -0.9% and the largest drop -30.2%.
VVOS fell in the first session after 5 of its last 5 EPS beats (100%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 3 of the 5 of those falls where price data is available, the stock had already risen before the report.
Across its last 11 quarters with price data, VVOS moved an average of -5.7% in the 20 trading sessions before reporting and was higher in 27% of them. After a run-up of 3% or more (3 quarters), it fell the next day 100% of the time, averaging -17.3%. After a drop of 3% or more (8 quarters), it rose the next day 0% of the time, averaging -10.3%. This describes past reports; it is not a forecast.
In 10 reports VVOS opened at least 1% away from the previous close. It gave back half or more of that gap by the close 1 of 10 times (10%), and fully reversed once. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · VVOS: 12 reported quarters, latest Aug 14, 2026. Information only, not investment advice.
Looking for more on VVOS?
Price charts, forecast, fundamentals and risk pages for VVOS are not on Tickzen yet. You can run a full stock analysis now.
Run the VVOS Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun